Mitchell, A. ., Watson, M. C., Welsh, T. J., & McGrogan, A. . (2025). Safety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods. Heart. http://doi.org/10.1136/heartjnl-2024-324763
Atrial fibrillation
Jones, N. R., Smith, M. ., Lay-Flurrie, S. ., Yang, Y. ., Hobbs, F. R., & Taylor, C. . (2025). Stroke incidence in heart failure and atrial fibrillation: population cohort study. Br J Gen Pract. http://doi.org/10.3399/bjgp.2024.0470
Jones, N. R., Smith, M. ., Lay-Flurrie, S. ., Yang, Y. ., Hobbs, F. R., & Taylor, C. J. (2024). Heart failure and major haemorrhage in people with atrial fibrillation. Open Heart, 11. http://doi.org/10.1136/openhrt-2024-002975
Graul, E. L., Nordon, C. ., Rhodes, K. ., Menon, S. ., Ammouri, A. ., Kallis, C. ., … Quint, J. K. (2024). Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study. BMC Pulm Med, 24, 221. http://doi.org/10.1186/s12890-024-03035-4
Chiv, R. ., Beradid, S. ., Suissa, S. ., & Renoux, C. . (2024). Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke. http://doi.org/10.1161/strokeaha.123.045098
Liaw, J. ., Liaw, D. ., & Dave, C. . (2024). Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020. Open Heart, 11. http://doi.org/10.1136/openhrt-2023-002515
Ajabnoor, A. M., Parisi, R. ., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C. ., Morris, C. ., … Kontopantelis, E. . (2023). Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019. Cancer. http://doi.org/10.1002/cncr.35152
Ajabnoor, A. M., Parisi, R. ., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C. ., Morris, C. ., … Kontopantelis, E. . (2023). Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Study in England. J Am Heart Assoc, 12, e029423. http://doi.org/10.1161/jaha.123.029423
Apenteng, P. N., Prieto-Merino, D. ., Hee, S. W., Lobban, T. C., Caleyachetty, R. ., & Fitzmaurice, D. A. (2023). Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records. Br J Gen Pract, 73, e816-e824. http://doi.org/10.3399/bjgp.2023.0082
Wu, J. ., Nadarajah, R. ., Nakao, Y. M., Nakao, K. ., Wilkinson, C. ., Cowan, J. C., … Gale, C. P. (2023). Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation. Eur Heart J. http://doi.org/10.1093/eurheartj/ehad571